Cargando…
Benefit versus toxicity risk of digoxin in patients with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614171/ https://www.ncbi.nlm.nih.gov/pubmed/34083222 http://dx.doi.org/10.1136/ejhpharm-2021-002880 |
| _version_ | 1784820135755776000 |
|---|---|
| author | Kelleci Cakir, Burcu Bayraktar-Ekincioglu, Aygin Demirkan, Kutay |
| author_facet | Kelleci Cakir, Burcu Bayraktar-Ekincioglu, Aygin Demirkan, Kutay |
| author_sort | Kelleci Cakir, Burcu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9614171 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96141712022-10-29 Benefit versus toxicity risk of digoxin in patients with COVID-19 Kelleci Cakir, Burcu Bayraktar-Ekincioglu, Aygin Demirkan, Kutay Eur J Hosp Pharm PostScript BMJ Publishing Group 2022-11 2021-06-02 /pmc/articles/PMC9614171/ /pubmed/34083222 http://dx.doi.org/10.1136/ejhpharm-2021-002880 Text en © European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. |
| spellingShingle | PostScript Kelleci Cakir, Burcu Bayraktar-Ekincioglu, Aygin Demirkan, Kutay Benefit versus toxicity risk of digoxin in patients with COVID-19 |
| title | Benefit versus toxicity risk of digoxin in patients with COVID-19 |
| title_full | Benefit versus toxicity risk of digoxin in patients with COVID-19 |
| title_fullStr | Benefit versus toxicity risk of digoxin in patients with COVID-19 |
| title_full_unstemmed | Benefit versus toxicity risk of digoxin in patients with COVID-19 |
| title_short | Benefit versus toxicity risk of digoxin in patients with COVID-19 |
| title_sort | benefit versus toxicity risk of digoxin in patients with covid-19 |
| topic | PostScript |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614171/ https://www.ncbi.nlm.nih.gov/pubmed/34083222 http://dx.doi.org/10.1136/ejhpharm-2021-002880 |
| work_keys_str_mv | AT kellecicakirburcu benefitversustoxicityriskofdigoxininpatientswithcovid19 AT bayraktarekinciogluaygin benefitversustoxicityriskofdigoxininpatientswithcovid19 AT demirkankutay benefitversustoxicityriskofdigoxininpatientswithcovid19 |